Lv32
240 积分 2025-02-05 加入
Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics
6小时前
已完结
POS0803 VUNAKIZUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, SEAMLESS, PHASE 2/3 STUDY
21天前
已关闭
Effect of IL-17A blockade with secukinumab in autoimmune diseases
23天前
已完结
Association of Ambient Particulate Matter Pollution of Different Sizes With In-Hospital Case Fatality Among Stroke Patients in China
1个月前
已完结
Long-term exposure to ambient fine particulate matter and fasting blood glucose level in a Chinese elderly cohort
1个月前
已完结
Predictors of response to treatment with biologics in people with moderate-to-severe psoriasis
2个月前
已关闭
Effects of TNF‐alpha antagonism in patients with metabolic syndrome and psoriasis
2个月前
已完结
Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis
3个月前
已关闭
Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review
3个月前
已完结
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series
3个月前
已完结
皖公网安备34019202002308
